Smoking Out the Cholinergic Component in Lung Cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Cancer Research

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-08-1465PMID 18980966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

  2008cited by this paper
• Retracted: Role of α7‐nicotinic acetylcholine receptor in human non‐small cell lung cancer proliferation

  2008cited by this paper
• A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

  2008cited by this paper
• Smoking out genetic components of lung cancer

  2008cited by this paper
• A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

  2008cited by this paper
• Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.

  2007cited by this paper
• Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors.

  2001cited by this paper
• Human Bronchial Epithelial and Endothelial Cells Express α7 Nicotinic Acetylcholine Receptors

  2001cited by this paper
• Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders.

  2000cited by this paper
• α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line

  1994cited by this paper
• Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma.

  1993cited by this paper

• Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.

  2012cites this paper
• Update in lung cancer 2008.

  2009cites this paper